Structured intermittent treatment for HIV disease: Necessary concession or premature compromise?
Proc Natl Acad Sci U S A
.
2002 Jan 8;99(1):4-6.
doi: 10.1073/pnas.022629399.
Author
Diane V Havlir
1
Affiliation
1
Division of Infectious Diseases, University of California, 150 West Washington Street, Suite 100, San Diego, CA 92103, USA. dhavlir@ucsd.edu
PMID:
11782542
PMCID:
PMC117502
DOI:
10.1073/pnas.022629399
No abstract available
MeSH terms
Anti-HIV Agents / therapeutic use*
Clinical Trials as Topic
HIV Infections / immunology
HIV Infections / mortality
HIV Infections / therapy*
Humans
Time Factors
Substances
Anti-HIV Agents